Phase I dose escalation
Sponsors
Tyligand Bioscience (Shanghai) Limited, Suzhou Genhouse Bio Co., Ltd.
Conditions
Advanced Solid Tumor CancerHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
Phase 1
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas
RecruitingNCT05842785
Start: 2023-07-26End: 2026-06-01Target: 162Updated: 2024-07-29
A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors
Not yet recruitingNCT07446725
Start: 2026-02-24End: 2029-12-31Target: 152Updated: 2026-03-03